In vitro combination therapy using low dose clotrimazole and photodynamic therapy leads to enhanced killing of the dermatophyte Trichophyton rubrum.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 4210577)

Published in BMC Microbiol on October 15, 2014

Authors

C Oliver Morton, Mousawi Chau, Colin Stack1

Author Affiliations

1: School of Science and Health, University of Western Sydney, Campbelltown Campus, Narellan Road, Campbelltown NSW 2560, Australia. c.stack@uws.edu.au.

Articles cited by this

Antifungal agents: mechanisms of action. Trends Microbiol (2003) 3.74

An update on photodynamic therapy applications. J Clin Laser Med Surg (2002) 2.94

Comparative and functional genomics provide insights into the pathogenicity of dermatophytic fungi. Genome Biol (2011) 1.34

Current management of fungal infections. Drugs (2001) 1.34

Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2002) 1.25

Dermatophytes: host-pathogen interaction and antifungal resistance. An Bras Dermatol (2010) 1.23

Enhanced bioavailability of poorly water-soluble clotrimazole by inclusion with beta-cyclodextrin. Arch Pharm Res (2007) 1.09

Photodynamic therapy with a cationic functionalized fullerene rescues mice from fatal wound infections. Nanomedicine (Lond) (2010) 1.09

Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform. Front Microbiol (2012) 1.07

Topical treatments for fungal infections of the skin and nails of the foot. Cochrane Database Syst Rev (2007) 1.06

A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin. J Photochem Photobiol B (2005) 1.06

Photodynamic antimicrobial chemotherapy (PACT) with methylene blue increases membrane permeability in Candida albicans. Lasers Med Sci (2007) 1.03

Mycology - an update. Part 1: Dermatomycoses: causative agents, epidemiology and pathogenesis. J Dtsch Dermatol Ges (2014) 1.01

In vitro antifungal drug susceptibilities of dermatophytes microconidia and arthroconidia. J Antimicrob Chemother (2008) 1.01

Susceptibility of Candida albicans to photodynamic therapy in a murine model of oral candidosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2010) 1.00

Antifungal drug resistance mechanisms in pathogenic fungi: from bench to bedside. Clin Microbiol Infect (2014) 0.99

Characterization of plant-derived saponin natural products against Candida albicans. ACS Chem Biol (2010) 0.97

Fungicidal effect of photodynamic therapy against fluconazole-resistant Candida albicans and Candida glabrata. Mycoses (2011) 0.96

Photodynamic antifungal chemotherapy. Photochem Photobiol (2012) 0.96

Tinea capitis update: a continuing conflict with an old adversary. Curr Opin Pediatr (2001) 0.93

Comparison of photodynamic action by Rose Bengal in gram-positive and gram-negative bacteria. Photochem Photobiol (1988) 0.93

Topical antifungal treatments for tinea cruris and tinea corporis. Cochrane Database Syst Rev (2014) 0.93

Assessment of rose bengal versus riboflavin photodynamic therapy for inhibition of fungal keratitis isolates. Am J Ophthalmol (2014) 0.92

Timing the multiple cell death pathways initiated by Rose Bengal acetate photodynamic therapy. Cell Death Dis (2011) 0.91

Intralesional injection of rose bengal induces a systemic tumor-specific immune response in murine models of melanoma and breast cancer. PLoS One (2013) 0.91

Inhibition of electron transport chain assembly and function promotes photodynamic killing of Candida. J Photochem Photobiol B (2010) 0.90

Photodynamic therapy for pathogenic fungi. Mycoses (2011) 0.89

Management of onychomycoses. Drugs (1999) 0.86

The rationale for combination therapy. Br J Dermatol (2001) 0.86

Correlation between adhesion, enzyme production, and susceptibility to fluconazole in Candida albicans obtained from denture wearers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2006) 0.85

Miconazole induces fungistasis and increases killing of Candida albicans subjected to photodynamic therapy. Photochem Photobiol (2011) 0.85

Novel use of Rose Bengal (PV-10) in two cases of refractory scalp sarcoma. ANZ J Surg (2013) 0.85

Enzyme-assisted cell photosensitization: a proposal for an efficient approach to tumor therapy and diagnosis. The rose bengal fluorogenic substrate. Photochem Photobiol (1997) 0.84

Topical rose bengal: pre-clinical evaluation of pharmacokinetics and safety. Lasers Surg Med (2003) 0.83

Photosensitizer accumulation in spontaneous multidrug resistant cells: a comparative study with Rhodamine 123, Rose Bengal acetate and Photofrine. Photochem Photobiol Sci (2002) 0.82

Enzyme-assisted photosensitization with rose Bengal acetate induces structural and functional alteration of mitochondria in HeLa cells. Histochem Cell Biol (2006) 0.82

Oral treatments for fungal infections of the skin of the foot. Cochrane Database Syst Rev (2012) 0.80

Clotrimazole as a pharmaceutical: past, present and future. J Appl Microbiol (2014) 0.79

An in vitro study of the photodynamic effect of rose bengal on Trichophyton rubrum. J Biophotonics (2012) 0.78

New agents to treat life-threatening fungal infections. Curr Top Med Chem (2008) 0.77

An investigation into the inhibitory effect of ultraviolet radiation on Trichophyton rubrum. Lasers Med Sci (2013) 0.76

Genotoxicity and carcinogenicity of the light emitted by artificial illumination systems. Arch Toxicol (2013) 0.76

The photodynamic action of rose bengal on Trypanosoma cruzi. Acta Trop (1984) 0.76